Browsing by Author Pérez, Antonio

Showing results 1 to 13 of 13
TitleAuthor(s)???itemlist.dc.contributor.advisor??????itemlist.dc.contributor.editor??????itemlist.dc.contributor.titulacion???Issue Date???itemlist.dc.identifier.doi??????itemlist.dc.source??????itemlist.dc.description.sjr??????itemlist.dc.description.sjrq??????itemlist.dc.description.jcr??????itemlist.dc.description.jcrq???TypePreview
Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patientsWägner, Ana M. ; Pérez, Antonio; Calvo, Fernando; Bonet, Rosa; Castellvi, Agustina, et al199910.2337/diacare.22.5.812Diabetes Care[ISSN 0149-5992],v. 22, p. 812-8175,076Q1Artículo
Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: Effect of glycemic controlPérez, Antonio; Wägner, Ana Maria ; Carreras, Gemma; Giménez, Gabriel; Sánchez-Quesada, Jose Luis, et al200010.1001/archinte.160.18.2756Archives of Internal Medicine[ISSN 0003-9926],v. 160, p. 2756-27626,055Q1Artículo
Apo(B)-dependent dyslipidemic phenotypes in type 1 diabetic patientsWägner, Ana Marı́a ; Ordóñez-Llanos, Jordi; Hernández, Marta; Luis Sánchez-Quesada, Jose; Blanco-Vaca, Francisco, et al200110.1016/S0953-6205(01)00178-9European Journal of Internal Medicine[ISSN 0953-6205],v. 12, p. 496-502Artículo
Diabetic dyslipidemia: Assessment and treatmentWägner, Ana M. ; Pérez, Antonio2002Medicina Clinica[ISSN 0025-7753],v. 119, p. 260-264Artículo
The effect of VLDL particles on the accuracy of a direct LDL-cholesterol method in type 2 diabetic patientsWägner, Ana María ; Zapico, Edgar; Bonet, Rosa; Pérez, Antonio; Ordóñez-Llanos, Jordi200310.1016/S0009-9120(03)00006-7Clinical Biochemistry[ISSN 0009-9120],v. 36, p. 177-1831,825Q2Artículo
Effect of improving glycemic control on low-density lipoprotein particle size in type 2 diabetesWägner, Ana María ; Jorba, Oscar; Rigla, Mercedes; Bonet, Rosa; De Leiva, Alberto, et al200310.1016/S0026-0495(03)00326-3Metabolism: Clinical and Experimental[ISSN 0026-0495],v. 52, p. 1576-15782,013Q3Artículo
Is necessary to reduce the LDL cholesterol level below 100 mg/dl in all diabetic patients? (multiple letters) [1]Wägner, Ana M. ; Pérez, Antonio200310.1157/13047699Medicina Clinica[ISSN 0025-7753],v. 120, p. 717-7181,018Q2Comentario
Postprandial lipidemia is normal in non-obese type 2 diabetic patients with relatively preserved insulin secretionWägner, Ana M. ; Ordóñez-Llanos, Jordi; Arcelus, Rosa; Bonet, Rosa; Jorba, Oscar, et al200310.1016/S0026-0495(03)00090-8Metabolism: Clinical and Experimental[ISSN 0026-0495],v. 52, p. 1038-10422,013Q3Artículo
Efficacy of atorvastatin and gemfibrozil, alone and in low dose combination, in the treatment of diabetic dyslipidemiaWägner, Ana M. ; Jorba, Oscar; Bonet, Rosa; Ordóñez-Llanos, Jordi; Pérez, Antonio200310.1210/jc.2003-030153Journal of Clinical Endocrinology and Metabolism[ISSN 0021-972X],v. 88, p. 3212-32175,873Q1Artículo
Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetesWägner, Ana M. ; Ordóñez-Llanos, Jordi; Jorba, Oscar; Pérez, Antonio200410.1016/j.metabol.2004.07.005Metabolism: Clinical and Experimental[ISSN 0026-0495],v. 53, p. 15162,143Q3Comentario
Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetesWägner, Ana María ; Pérez, Antonio; Sánchez-Quesada, Jose Luis; Ordóñez-Llanos, Jordi200510.2337/diacare.28.7.1798Diabetes Care[ISSN 0149-5992],v. 28, p. 1798-18007,844Q1Artículo
Electronegative low-density lipoprotein subfraction from type 2 diabetic subjects is proatherogenic and unrelated to glycemic controlBenítez, Sónia; Pérez, Antonio; Sánchez-Quesada, José Luis; Wagner, Ana María ; Rigla, Mercedes, et al200710.1002/dmrr.643Diabetes/Metabolism Research and Reviews[ISSN 1520-7552],v. 23, p. 26-343,087Q2Artículo
Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over studyWägner, Ana María ; Sánchez-Quesada, Jose Luis; Benítez, Sonia; Bancells, Cristina; Ordóñez-Llanos, Jordi, et al201110.1016/j.diabres.2011.03.009Diabetes Research and Clinical Practice [ISSN 0168-8227], v. 93 (1), p. E25-E28, (Julio 2011)0,96Q12,754Q2Artículo